Other Clinical Trial - Optimal Index for Pediatric Distal Forearm

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This is a prospective radiographic study of displaced distal forearm fractures requiring manipulation for children 3-12 years of age and will be treated with casting.The patients' full radiographic series (including the pre-manipulation, immediate post-manipulation, after 1 week and after 4 weeks radiographs) will be evaluated.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01101607` - Closed Reduction of Distal Forearm Fractures by Pediatric Emergency Medicine Physicians: A Prospective Study	N/A

NCT number	NCT05425758
Study type	Observational
Source	Sohag University
Contact
Status	Not yet recruiting
Phase
Start date	July 1, 2022
Completion date	November 30, 2022

Optimal Index for Pediatric Distal Forearm Fractures

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms